Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/23/20241:11AMPR Newswire (US)Flex LNG - First Quarter 2024 PresentationNYSE:FLNGFLEX LNG Ltd
05/23/20241:01AMGlobeNewswire Inc.Benedicte Schilbred Fasmer is appointed new President & CEO in Telenor GroupTG:TEQTelenor ASA
05/23/20241:01AMGlobeNewswire Inc.Avance Gas Holding Ltd: Ex cash distribution USD 2.15 todayTG:A07Avance Gas Holding Ltd
05/23/20241:00AMGlobeNewswire Inc.EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’eurosTG:940Euroapi SA
05/23/20241:00AMBusiness WireFiberwood lève 7,7 millions d'euros pour le développement de matériaux écologiques d'isolation et d'emballage
05/23/20241:00AMGlobeNewswire Inc.EUROAPI strengthens its presence in animal health with a €130-150 million supply contractTG:940Euroapi SA
05/23/20241:00AMBusiness WireFiberwood nimmt 7,7 Mio. Euro zur Entwicklung umweltfreundlicher Gebäudedämmungs- und Verpackungsmaterialien auf
05/23/20241:00AMGlobeNewswire Inc.AvH annonce d'excellents résultats au premier trimestre, tant pour DEME que pour les banques privées Delen et Van Breda, et confirme ses perspectives: le bénéfice net pour 2024 devrait être supérieur à celui de l'année dernièreTG:B3KAckermans and Van Haaren NV
05/23/20241:00AMGlobeNewswire Inc.IBA Business Update – First Quarter 2024TG:IOBIon Beam Applications SA
05/23/20241:00AMBusiness WireFiberwood Raises €7.7 Million for the Development of Ecological Building Insulation and Packaging Materials
05/23/20241:00AMGlobeNewswire Inc.Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney DiseaseTG:05YVivoryon Therapeut
05/23/20241:00AMGlobeNewswire Inc.Start of Day Message
05/23/20241:00AMGlobeNewswire Inc.IBA déclaration intermédiaire - Premier trimestre 2024EU:IBABIon Beam Applications SA
05/23/20241:00AMBusiness WireGalderma Launches Restylane® VOLYME™ in China – One of the World’s Fastest Growing Aesthetics Markets
05/23/20241:00AMGlobeNewswire Inc.IBA Business Update – First Quarter 2024EU:IBABIon Beam Applications SA
05/23/20241:00AMBusiness WireElectronic Elections: Half of Brits More Likely to Vote If They Could Vote Electronically
05/23/20241:00AMBusiness WireZilch Surpasses 4 Million Customer Milestone in 44 Months
05/23/20241:00AMGlobeNewswire Inc.EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’eurosEU:EAPIEuroapi SA
05/23/20241:00AMGlobeNewswire Inc.IBA déclaration intermédiaire - Premier trimestre 2024TG:IOBIon Beam Applications SA
05/23/20241:00AMGlobeNewswire Inc.Boyden Greece & Cyprus Expands its Operations in Malta, with Vassilis Trochalidis to Lead the Maltese Office
05/23/20241:00AMGlobeNewswire Inc.Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney DiseaseEU:VVYVivoryon Therapeut
05/23/20241:00AMGlobeNewswire Inc.Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last yearEU:ACKBAckermans and Van Haaren NV
05/23/20241:00AMGlobeNewswire Inc.EUROAPI strengthens its presence in animal health with a €130-150 million supply contractEU:EAPIEuroapi SA
05/23/20241:00AMGlobeNewswire Inc.Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last yearTG:B3KAckermans and Van Haaren NV
05/23/20241:00AMGlobeNewswire Inc.AvH annonce d'excellents résultats au premier trimestre, tant pour DEME que pour les banques privées Delen et Van Breda, et confirme ses perspectives: le bénéfice net pour 2024 devrait être supérieur à celui de l'année dernièreEU:ACKBAckermans and Van Haaren NV
05/23/20241:00AMGlobeNewswire Inc.Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney DiseaseLSE:0R3MVivoryon Therapeutics Nv
05/23/202412:54AMBusiness WireHiground、マインクラフトと共同で「アートとしてのゲーム」をお披露目
05/23/202412:48AMAlliance NewsAlliance NewsChina holds military drills around Taiwan as 'punishment'
05/23/202412:47AMAlliance NewsAlliance NewsRiders, shareholders to press Deliveroo on pay, job security at AGMLSE:ROODeliveroo Plc
05/23/202412:47AMAlliance NewsAlliance NewsRiders, shareholders to press Deliveroo on pay, job security at AGMLSE:ROODeliveroo Plc